Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine

被引:70
作者
Conway, KJ [1 ]
Orr, R [1 ]
Stannard, SR [1 ]
机构
[1] Univ Sydney, Sch Exercise & Sport Sci, Lidcombe, NSW 1825, Australia
关键词
urine; doping;
D O I
10.1152/japplphysiol.00911.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
This study compared the effects of a single and divided dose of caffeine on endurance performance and on postexercise urinary caffeine and plasma paraxanthine concentrations. Nine male cyclists and triathletes cycled for 90 min at 68% of maximal oxygen uptake, followed by a self-paced time trial (work equivalent to 80% of maximal oxygen uptake workload over 30 min) with three randomized, balanced, and double-blind interventions: 1) placebo 60 min before and 45 min into exercise (PP); 2) single caffeine dose (6 mg/kg) 60 min before exercise and placebo 45 min into exercise (CP); and 3) divided caffeine dose (3 mg/kg) 60 min before and 45 min into exercise (CC). Time trial performance was unchanged with caffeine ingestion (P = 0.08), but it tended to be faster in the caffeine trials (CP: 24.2 min and CC: 23.4 min) compared with placebo (PP: 28.3 min). Postexercise urinary caffeine concentration was significantly lower in CC (3.8 mug/ml) compared with CP (6.8 mug/ml). Plasma paraxanthine increased in a dose-dependent fashion and did not peak during exercise. In conclusion, dividing a caffeine dose provides no ergogenic effect over a bolus dose but reduces postexercise urinary concentration.
引用
收藏
页码:1557 / 1562
页数:6
相关论文
共 29 条
[1]  
Arnaud MJ, 1993, CAFFEINE COFFEE HLTH, P43
[2]   Sympathomimetic effects of paraxanthine and caffeine in humans [J].
Benowitz, NL ;
Jacob, P ;
Mayan, H ;
Denaro, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) :684-691
[3]   EFFECTS OF CAFFEINE INGESTION ON EXERCISE PERFORMANCE AT LOW AND HIGH-ALTITUDES IN CROSS-COUNTRY SKIERS [J].
BERGLUND, B ;
HEMMINGSSON, P .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1982, 3 (04) :234-236
[4]   THE ABSOLUTE BIOAVAILABILITY OF CAFFEINE IN MAN [J].
BLANCHARD, J ;
SAWERS, SJA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) :93-98
[5]   EFFECTS OF MODERATE EXERCISE ON THE PHARMACOKINETICS OF CAFFEINE [J].
COLLOMP, K ;
ANSELME, F ;
AUDRAN, M ;
GAY, JP ;
CHANAL, JL ;
PREFAUT, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) :279-282
[6]  
COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
[7]   Effect of different protocols of caffeine intake on metabolism and endurance performance [J].
Cox, GR ;
Desbrow, B ;
Montgomery, PG ;
Anderson, ME ;
Bruce, CR ;
Macrides, TA ;
Martin, DT ;
Moquin, A ;
Roberts, A ;
Hawley, JA ;
Burke, LM .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (03) :990-999
[8]  
COYLE EF, 1984, CLIN SPORT MED, V3, P731
[9]   Doping in cyclism: Results of unannounced controls in Flanders (1987-1994) [J].
Delbeke, FT .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1996, 17 (06) :434-438
[10]   Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance [J].
Denaro, CP ;
Wilson, M ;
Jacob, P ;
Benowitz, NL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (03) :284-296